Organisation paid for research Program year 2021 Source: CMS Open Payments

Bernstein Clinical Res Ctr

Neither a doctor nor a teaching hospital

Research payments

$75,540

51 payments

Through program year 2021, Bernstein Clinical Res Ctr is reported as receiving $75,540 in research payments, across 51 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$18,639	7
2020	Research	$56,901	44

Breakdown

Who paid Research payments · program years 2020–2021

BioCryst Pharmaceuticals, Inc. $75,540 51 payments

Studies the money was for Research payments · program years 2020–2021

An Open-label Study to Evaluate the Long-term Safety of Daily Oral BCX7353 in Subjects With Type I and II Hereditary Angioedema $54,405 31 payments
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema $14,400 17 payments
A Phase 3 Randomized Double-blind Placebo-controlled Parallel Group Study to Evaluate the Efficacy and Safety of Two Dose Levels of BCX7353 as an Oral Treatment for the Prevention of Attacks in Subjects With Hereditary Angioedema $6,735 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.